Showing results (41-50 of 147) with videos related to
Sort By:
Pageof 15
Current Treatment Options in Oncology|June 26, 2010
Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?Millie Das, Mohamed H K Abdelmaksoud, Billy W Loo, et al.Journal of Neuro-Oncology|October 13, 2022
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancerCaressa Hui, Vera Qu, Jen-Yeu Wang, et al.Cancer Cell|March 10, 2021
Women in cancer research and oncologyJohanna Joyce, Heather Wakelee, Melissa B Davis, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 yearsManali I Patel, Meg McKinley, Iona Cheng, et al.Clinical Lung Cancer|May 27, 2008
Complications of ablative therapies in lung cancerSukhmani Padda, Nishita Kothary, Jessica Donington, et al.Immunotherapy|April 6, 2023
Cost-effectiveness of adjuvant atezolizumab for patients with stage II-IIIA PD-L1+ non-small-cell lung cancerMillie Das, Sarika Ogale, Nick Jovanoski, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancerJeremy P Harris, Chika Nwachukwu, Yushen Qian, et al.Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health InitiativeMeng-Hua Tao, Qi Dai, Shande Chen, et al.Lung Cancer (Amsterdam, Netherlands)|July 8, 2015
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interactionMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.Cancer Investigation|October 5, 2022
Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020Ryan S Chiang, Aakash Desai, Michael J Glover, et al.Pageof 15